Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.

Abbadessa G, Chianese U, Russo C, Miele G, Maida E, Esposito G, Romano G, Bile F, Signoriello E, Lus G, et al.

Neurol Neuroimmunol Neuroinflamm. 2026 Sep; 13(5):e200634. PMID: 42579840. Abstract